- Home
- NUVB vs VMEO Comparison
NUVB vs VMEO Comparison
Compare NUVB & VMEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- VMEO
- Stock Information
- Founded
- NUVB 2018
- VMEO 2004
- Country
- NUVB United States
- VMEO United States
- Employees
- NUVB N/A
- VMEO N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- VMEO Computer Software: Prepackaged Software
- Sector
- NUVB Health Care
- VMEO Technology
- Exchange
- NUVB Nasdaq
- VMEO Nasdaq
- Market Cap
- NUVB 959.2M
- VMEO 1.1B
- IPO Year
- NUVB N/A
- VMEO N/A
- Fundamental
- Price
- NUVB $2.67
- VMEO $6.72
- Analyst Decision
- NUVB Strong Buy
- VMEO Buy
- Analyst Count
- NUVB 6
- VMEO 4
- Target Price
- NUVB $6.33
- VMEO $7.50
- AVG Volume (30 Days)
- NUVB 2.7M
- VMEO 1.6M
- Earning Date
- NUVB 11-06-2024
- VMEO 11-04-2024
- Dividend Yield
- NUVB N/A
- VMEO N/A
- EPS Growth
- NUVB N/A
- VMEO 290.90
- EPS
- NUVB N/A
- VMEO 0.20
- Revenue
- NUVB $2,162,000.00
- VMEO $419,394,000.00
- Revenue This Year
- NUVB N/A
- VMEO $1.32
- Revenue Next Year
- NUVB N/A
- VMEO $2.07
- P/E Ratio
- NUVB N/A
- VMEO $34.00
- Revenue Growth
- NUVB N/A
- VMEO 0.52
- 52 Week Low
- NUVB $1.43
- VMEO $3.43
- 52 Week High
- NUVB $4.16
- VMEO $7.90
- Technical
- Relative Strength Index (RSI)
- NUVB 48.20
- VMEO 52.20
- Support Level
- NUVB $2.51
- VMEO $6.38
- Resistance Level
- NUVB $2.87
- VMEO $7.06
- Average True Range (ATR)
- NUVB 0.17
- VMEO 0.34
- MACD
- NUVB -0.02
- VMEO -0.10
- Stochastic Oscillator
- NUVB 30.77
- VMEO 29.76
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. Its comprehensive and cloud-based tools empower its users to create, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.